Literature DB >> 17567768

Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.

Ramapraba Appanna1, Tan Lian Huat, Lucy Lum Chai See, Phoay Lay Tan, Jamuna Vadivelu, Shamala Devi.   

Abstract

Dengue virus infections are a major cause of morbidity and mortality in tropical and subtropical areas in the world. Attempts to develop effective vaccines have been hampered by the lack of understanding of the pathogenesis of the disease and the absence of suitable experimental models for dengue viral infection. The magnitude of T-cell responses has been reported to correlate with dengue disease severity. Sixty Malaysian adults with dengue viral infections were investigated for their dengue virus-specific T-cell responses to 32 peptides antigens from the structural and nonstructural regions from a dengue virus isolate. Seventeen different peptides from the C, E, NS2B, NS3, NS4A, NS4B, and NS5 regions were found to evoke significant responses in a gamma interferon enzyme-linked immunospot (ELISPOT) assay of samples from 13 selected patients with dengue fever (DF) and dengue hemorrhagic fever (DHF). NS3 and predominantly NS3(422-431) were found to be important T-cell targets. The highest peaks of T-cell responses observed were in responses to NS3(422-431) and NS5(563-571) in DHF patients. We also found almost a sevenfold increase in T-cell response in three DHF patients compared to three DF patient responses to peptide NS3(422-431). A large number of patients' T cells also responded to the NS2B(97-106) region. The ELISPOT analyses also revealed high frequencies of T cells that recognize both serotype-specific and cross-reactive dengue virus antigens in patients with DHF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567768      PMCID: PMC2044482          DOI: 10.1128/CVI.00069-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  51 in total

1.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

Authors:  H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

Review 2.  Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large.

Authors:  I Kurane; T Takasaki
Journal:  Rev Med Virol       Date:  2001 Sep-Oct       Impact factor: 6.989

3.  T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.

Authors:  Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

Review 4.  The future of dengue vaccines.

Authors:  Scott B Halstead; Jacqueline Deen
Journal:  Lancet       Date:  2002-10-19       Impact factor: 79.321

Review 5.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

Authors:  H A F Stephens; R Klaythong; M Sirikong; D W Vaughn; S Green; S Kalayanarooj; T P Endy; D H Libraty; A Nisalak; B L Innis; A L Rothman; F A Ennis; D Chandanayingyong
Journal:  Tissue Antigens       Date:  2002-10

7.  Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus.

Authors:  Anita E Matusan; Peter G Kelley; Melinda J Pryor; James C Whisstock; Andrew D Davidson; Peter J Wright
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

8.  Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand.

Authors:  Timothy P Endy; Supamit Chunsuttiwat; Ananda Nisalak; Daniel H Libraty; Sharone Green; Alan L Rothman; David W Vaughn; Francis A Ennis
Journal:  Am J Epidemiol       Date:  2002-07-01       Impact factor: 4.897

9.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

Authors:  Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Xiao-ning Xu; Sirijitt Vasanawathana; Nattaya Tangthawornchaikul; Aroonrung Chairunsri; Siraporn Sawasdivorn; Thaneeya Duangchinda; Tao Dong; Sarah Rowland-Jones; Pa-thai Yenchitsomanus; Andrew McMichael; Prida Malasit; Gavin Screaton
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

10.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

View more
  35 in total

1.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.

Authors:  G N Malavige; S McGowan; V Atukorale; M Salimi; M Peelawatta; N Fernando; S D Jayaratne; G Ogg
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

4.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

5.  Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.

Authors:  Daniela Weiskopf; Lauren E Yauch; Michael A Angelo; Daisy V John; Jason A Greenbaum; John Sidney; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Howard Grey; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

6.  Identification of Dengue-specific B-Cell Epitopes by Phage-display Random Peptide Library.

Authors:  Nevis Amin; Alicia Aguilar; Frank Chamacho; Yaime Vázquez; Maritza Pupo; Juan Carlos Ramirez; Luis Izquierdo; Felix Dafhnis; David Ian Stott; Ela Maria Perez; Armando Acosta
Journal:  Malays J Med Sci       Date:  2009-10

7.  Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.

Authors:  Georg F Bischof; Diogo M Magnani; Michael Ricciardi; Young C Shin; Aline Domingues; Varian K Bailey; Lucas Gonzalez-Nieto; Eva G Rakasz; David I Watkins; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.

Authors:  Kerrie Vaughan; Jason Greenbaum; Martin Blythe; Bjoern Peters; Alessandro Sette
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

9.  Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population.

Authors:  Ramapraba Appanna; Sasheela Ponnampalavanar; Lucy Lum Chai See; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

10.  Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Authors:  Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.